1 rich Libsyn https://www.libsyn.com 90 600 Tom Krohn is the Chief Development Officer at Antidote. In this episode, Tom details a collaboration between phaware global association® and Antidote Technologies to accelerate lung disease research. This partnership provides pharmaceutical companies with end-to-end clinical trial recruitment services through an extensive network of patients with chronic lung diseases. Tom is an experienced executive leader in multiple healthcare and IT settings including sub-Saharan Africa development, US hospital and retail pharmacies, and the pharmaceutical industry. He has a personal passion and commitment to use his talents to serve the marginalized of society. Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube &amp;amp; Linkedin Engage for a cure: www.phaware.global/donate #phaware&amp;nbsp;@antidote_me @accpchest&amp;nbsp; I'm Aware That I'm Rare: the phaware® podcast http://phawarepodcast.libsyn.com/podcast <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/7049162/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/87A93A/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/23304912